Drugs of Abuse Testing Market is projected to reach USD 3,720 Million by 2025, exhibiting a 5.4% CAGR during forecast period (2018-2025), due to the growing application of illegal drugs for recreational purposes.

To have an edge over the competition by knowing the market dynamics and current trends of “Drugs of Abuse Testing Market”, request for Sample Report here

Key Drivers

The drug of abuse testing market is expected to witness a significant growth over the upcoming years, due to the growing demand for drug abuse testing and strategic government initiatives, including rigorous norms mandating drug testing and programs to overcome drug abuse. As stated by the United Nations Office on Drugs and Crime (UNODC) 2019 data, approximately 55% of the substance use disorders are related with opioids and 25% with marijuana. Also, the US government funded over 60 inpatient and outpatient drug treatment centers across the country. Drug abuse testing helps in managing acute mental status in the emergency room and identifying children at risk of exposure to illicit drugs, which is projected to expand the market growth. Increasing demand for drug abuse testing across workplace to screen job applicants and employees as drug abuse can significantly reduce the productivity and morale of an individual, will bolster the Drugs of Abuse Testing Market size.

With the growing demand for drug abuse testing, various leading players are emphasizing on expanding their product portfolios by adding products and updating software, which include automated testing and at-home use kits for instant drug abuse tests, driving the market growth. Other factors including the growing demand for drug addiction treatment, increasing incidences of drug-related mortality, technological advancements, and minimal time required for testing, are projected to expand the market growth. For instance, In April 2020, Cordant Health Solutions began a telemedicine-based oral fluid drug testing solution to assist in providing critical care to individuals recovering from substance use disorder. However, legalization of illicit drugs, social issues associated with the drug of abuse testing, inability to detect low-dose designer drugs, and lack of a global standard definition of a problem drug user are expected to restrain the drugs of abuse testing market.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Sample Type Segment Analysis

Urine sample type is expected to lead the market over the upcoming years. Increasing use of urine analysis for drug abuse testing in cases for in several cases for workplace drug abuse, criminal justice cases, will add to the segment’s growth. Also, rising deaths due to drug overdose, ongoing technological innovations in drug abuse testing, and the growing demand for drug tests have augmented the use of urine analysis, further propelling the market growth.
Hair sample is forecast to hold a larger share over the forecast period, as hair serves to be a powerful sample tool by providing up to 3-month history of drug abuse. Moreover, these samples are easy to collect, ideal for screening and appearance of drug biomarkers for longer timespan will add to the segment’s growth.

Product Type Segment Analysis

Immunoassays analyzers are projected to grow at a faster pace over the forthcoming years, due to the growing demand for disposable blood testing devices. In addition, the ease of operation, simplicity, on- the spot results, and lower cost of these analyzers will bolster the market growth. The assays operate on automated systems, which provide faster, precise, and accurate, results, which has encouraged their adoption, thus, proliferating the market. The rapid testing devices will witness a higher CAGR over the upcoming year, as they offer an on-site screening for drugs of abuse, and saliva alcohol, thus, allowing immediate action.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional Analysis

North America is estimated to emerge as the fastest growing nation over the forecast period, due to the strategic initiatives by the United States to administer the symptoms. The Centers for Disease Control and Prevention (CDC) introduced four education campaigns in 2022 intending to prevent drug overdose deaths. The growing dependence on opioid will further boost the regional growth. According to the National Centre for Drug Abuse Statistics, nearly 53 million individuals above 12 years use illegal drugs or have misused prescription drugs. Growing adoption of technologically advanced products for drug abuse testing along with the growing demand for illicit drugs have stimulated the market growth.

Asia Pacific is anticipated to witness lucrative growth over the forecast period, due to the growing demand for substance abuse testing services across developing nations like China and India. The rising incidences of substance abuse disorders in and strategic initiatives undertaken by regulatory bodies will further strengthen the regional growth.

Top Market Players

Various notable players operating in the market, include F. Hoffmann La-Roche Ltd, Siemens Healthineers (Siemens AG), Thermo Fisher Scientific, Inc., Quest Diagnostics, Alere, Inc., Shimadzu Corporation, Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Randox Testing Services, Biomedical Diagnostics, BioMerieux, Bio-Rad, among others.

Segments covered in the Report:

The global drugs of abuse testing market is segmented on the basis of product type, drug type, technique type, end user and key geographies. Based on product type, the market comprises instruments and consumables. The research report “global drugs of abuse testing market” provides in-depth analysis of global drugs of abuse testing market based on product type, drug type, technique type, end user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global drugs of abuse testing market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For detailed scope of the “Drugs of Abuse Testing Market” report request a Sample Copy of the report

Key questions answered in this research report:
1. At what pace is drugs of abuse testing market growing? What will be the growth trend in the future?
2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3. What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the drugs of abuse testing market?
4. What are the various application areas and how they are poised to grow?

Market Segmentation

By Product Type
• Instruments
o Analyzers
■ Immunoassays Analyzers
■ Chromatographic Devices
■ Breath Analyzers
o Rapid Testing Devices
■ Urine Testing Devices
■ Oral Fluid Testing Device
• Consumables
o Rapid test kits
o Assay kits & reagents
o Others

By Drug Type
• Psychostimulants
• Narcotic
• Hallucinogens
• Sedatives
• Others

By Technique Type
• Immunoassay
• Chromatography
• Rapid Testing

By End User
• Hospitals
• Diagnostic Laboratories
• Forensic Laboratories
• Government and private departments
• Others

By Geography
• North America
As a part of the customization
o By Product Type
o By Drug Type
o By Technique Type
o By End User
o US
o Canada
o Mexico

• Europe
As a part of the customization
o By Product Type
o By Drug Type
o By Technique Type
o By End User
o UK
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of the customization
o By Product Type
o By Drug Type
o By Technique Type
o By End User
o China
o Australia
o India
o Rest of APAC

• ROW
As a part of the customization
o By Product Type
o By Drug Type
o By Technique Type
o By End User
o Brazil
o South Africa
o GCC countries
o Rest of world (remaining countries of the LAMEA region)

Leading market players
• F. Hoffmann La-Roche Ltd
• Siemens Healthineers (Siemens AG)
• Thermo Fisher Scientific, Inc.
• Quest Diagnostics
• Alere, Inc.
• Shimadzu Corporation
• Drägerwerk AG & Co. KGaA
• Laboratory Corporation of America Holdings

*Other prominent players in the market which can be profiled as a part of customization:
• United States Drug Testing Laboratories, Inc
• Express Diagnostics International Inc.
• LGC Limited
• Randox Testing Services
• Biomedical Diagnostics
• BioMerieux
• Bio-Rad